na-931
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 6, 2024 (NCT06615700)
Timeline
Indications
Mechanism of action
- Glucagon receptorAGONIST
GCGR agonist
GIPR agonist
GLP1R agonist
IGF1R agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06732245 | Phase 2 | Mar 15, 2025 | Biomed Industries, Inc. |
| NCT06564753 | Phase 2 | Aug 19, 2024 | Biomed Industries, Inc. |
| NCT06615700 | Phase 1 | May 6, 2024 | Biomed Industries, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biomed Industries, Inc. | For profit | 3 | 3 | 2 | 2024 |
1 organizations
Page 1 / 1